Journal of Endocrinological Investigation

, Volume 10, Issue 1, pp 95–104 | Cite as

Opioid peptides and glucose metabolism

  • A. Lala
  • P. Bouloux
  • G. Tamburrano
  • E. Gale
Review Article


Opioids opiate receptor insulin glucagon somatostatin naloxone 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cryer P.E. Glucose homeostasis and hypoglycemia. In: Wilson J.D., Foster D.W. (Eds.), Williams textbook of endocrinology. Saunders, Philadelphia, 1985, p. 989.Google Scholar
  2. 2.
    North R.A., Egan T.M. Action and distributions of opioid peptides in peripheral tissues. Br. Med. Bull. 39: 71, 1983.PubMedGoogle Scholar
  3. 3.
    Smyth D.G. α-endorphin and related peptides in pituitary, brain, pancreas and antrum. Br. Med. Bull. 39: 25, 1983.PubMedGoogle Scholar
  4. 4.
    Krieger D.T., Martin J.B. Brain peptides (first part). N. Engl. J. Med. 304: 876, 1981.PubMedCrossRefGoogle Scholar
  5. 5.
    Hughes J. Biogenesis, release and inactivation of enkephalins and dynorphins. Br. Med. Bull. 39: 17, 1983.PubMedGoogle Scholar
  6. 6.
    Thompson J.W. Opioid peptides. Br. Med. J. 288: 259, 1984.CrossRefGoogle Scholar
  7. 7.
    Paterson S.J., Robson L.E., Kosterlitz H.W. Classification of opioid receptors. Br. Med. Bull. 39: 31, 1983.PubMedGoogle Scholar
  8. 8.
    Feldberg W., Pyke D.A., Stubbs W.A. Hyperglycaemia: imitating Claude Bernard’s piqure with drugs. J. Autonom. Ner. Syst. (in press).Google Scholar
  9. 9.
    Feldberg W.S., Shaligram S.V. The hyperglycaemic effect of morphine. Br. J. Pharmacol. 46: 602, 1972.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Van Loon G.R., Appel N.M. β-endorphin-induced increases in plasma dopamine, norepinephrine and epinephrine. Res. Commun. Chem. Pathol. Pharmacol. 27: 607, 1980.PubMedGoogle Scholar
  11. 11.
    Van Loon G.R., Appel N.M. β-endorphin-induced hyperglycaemia is mediated by increased central sympathetic outflow to adrenal medulla. Brain Res. 204: 236, 1981.PubMedCrossRefGoogle Scholar
  12. 12.
    Iguchi A., Matsunaga H., Nomura T., Gotoh M., Sakamoto N. Glucoregulatory effects of intrahypothalamic injections of bombesin and other peptides. Endocrinology 114: 2242, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Helman A.M., Giraud P., Nicolaidis S., Oliver C., Assan R. Glucagon release after stimulation of the lateral hypothalamic area in rats: predominant β-adrenergic transmission and involvement of endorphin pathways. Endocrinology 113: 1, 1983.PubMedCrossRefGoogle Scholar
  14. 14.
    Feldberg W., Pyke D.A., Stubbs W.A. On the origin of non-insulin dependent diabetes. Lancet 1: 1263, 1985.PubMedCrossRefGoogle Scholar
  15. 15.
    Feldberg W., Pyke D.A., Stubbs W.A. Hyperglycaemia, a morphine-like effect produced by naloxone in cat. J. Physiol. 340: 121, 1983.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Sawynok J., Pinsky C., LaBella F.S. Minireview on the specificity of naloxone as an opiate antagonist. Life Sci. 25: 1621, 1979.PubMedCrossRefGoogle Scholar
  17. 17.
    Ipp E., Garberoglio C., Richter H., Moossa R.A., Rubenstein A.H. Naloxone decreases centrally induced hyperglycaemia in dogs. Evidence for an opioid role in glucose homeostasis. Diabetes 33: 619, 1984.PubMedCrossRefGoogle Scholar
  18. 18.
    Matsumura M., Fukushima T., Saito H., Saito S. In vivo and in vitro effects of α-endorphin on glucose metabolism in the rat. Horm. Metab. Res. 16: 27, 1984.PubMedCrossRefGoogle Scholar
  19. 19.
    Allan H.L., Green C., Titheradge A. The stimulation of glycogenolysis and gluconeogenesis in isolated hepatocytes by opioid peptides. Biochem. J. 216: 507, 1983.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Radosevich P.M., Williams P.E., Brooks-Lacy D., McRae J.R., Steiner K.E., Cherrington A.D., Lacy W.W., Abumrad N.N. Effects of morphine on glucose homeostasis in the conscious dog. J. Clin. Invest. 74: 1473, 1984.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Radosevich P.M., Williams P.E., McRae J.R., Lacy W.W., Orth D.N., Abumrad N.N. β-endorphin inhibits glucose production in the conscious dog. J. Clin. Invest. 73: 1237, 1984.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    El-Tayeb K.M., Brubacker P.L., Vranic M., Lickley L.A. β-endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogs. Diabetes 34: 1293, 1985.PubMedCrossRefGoogle Scholar
  23. 23.
    Werther G.A., Joffe S., Artal R., Sperling M.A. Opiate modulation of glucose turnover in dogs. Metabolism 34: 136, 1985.PubMedCrossRefGoogle Scholar
  24. 24.
    Werther G.A., Joffe S., Artal R., Sperling M.A. Opiates modulate insulin action in vivo in dogs. Diabetologia 26: 65, 1984.PubMedCrossRefGoogle Scholar
  25. 25.
    Ipp E., Dhorajiala J., Pugh W., Moossa A.R., Rubenstain A.H. Effects of an enkephalin analog on pancreatic endocrine function and glucose homeostasis in normal and diabetic dogs. Endocrinology 111: 2110, 1982.PubMedCrossRefGoogle Scholar
  26. 26.
    Bruni J.F., Watkins W.B., Yen S.S.C. β-endorphin in the human pancreas. J. Clin. Endocrinol. Metab. 49: 649, 1979.PubMedCrossRefGoogle Scholar
  27. 27.
    Grube D., Voigt K.H., Weber E. Pancreatic glucagon cells contain enkephalin-like immunoreactivity. Histochemistry 59: 75, 1978.PubMedCrossRefGoogle Scholar
  28. 28.
    Forsmann W.G., Helmstaedter V., Feurle G. Relationship of enkephalin and endorphin immunoreactivity with D-cells and G-cells of stomach. Acta Hepatogastroenterol. 24: 488, 1977.Google Scholar
  29. 29.
    Ipp E., Dobbs R., Unger R.H. Morphine and α-endorphin influence the secretion of the endocrine pancreas. Nature 276: 190, 1978.PubMedCrossRefGoogle Scholar
  30. 30.
    Hermansen K. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Endocrinology 113: 1149, 1983.PubMedCrossRefGoogle Scholar
  31. 31.
    Rudman D., Berry C.I., Riedburg C.H., Hollins B.M., Kutner M.H., Lynn M.J., Chawla R.K. Effects of opioid peptides and opiate alkaloids on insulin secretion in the rabbit. Endocrinolgy 112: 1702, 1983.CrossRefGoogle Scholar
  32. 32.
    Pierluissi R., Pierluissi J., Ashcroft S.J.K. Effects of an enkephalin analogue (DAMME) on insulin release from cultured rat islets of Langerhans. Diabetologia 20: 642, 1981.PubMedCrossRefGoogle Scholar
  33. 33.
    Kanter R.A., Ensink. J.W., Fujimoto W.J. Disparate effects of enkephalin and morphine upon insulin and glucagon secretion by islet cell cultures. Diabetes 29: 84, 1980.PubMedCrossRefGoogle Scholar
  34. 34.
    Green I.C., Perrin D., Pedley K.C., Leslie R.D.G., Pyke D. Effect of enkephalins and morphine on insulin secretion from isolated rat islets. Diabetologia 19: 158, 1980.PubMedCrossRefGoogle Scholar
  35. 35.
    Sachse G., Laube H., Svedberg J., Breidenbach T., Teschemacher H. Opiates influence endocrine pancreas secretion. Diabetologia 21: 322, 1981 (Abstract).Google Scholar
  36. 36.
    Green I.E., Ray K., Perrin D. Opioid peptide effects on insulin release and c-AMP in islets of Langerhans. Horm. Metab. Res. 15: 124, 1983.PubMedCrossRefGoogle Scholar
  37. 37.
    Ryder S., Gollapudi G.M., Ryder D. Morphine sulfate inhibits insulin release from isolated, superinfused rat pancreatic islets. Horm, Metab. Res. 12: 412, 1980.CrossRefGoogle Scholar
  38. 38.
    Green I.E., Perrin D., Penman E., Yaseen A., Ray K., Howel S.L. Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans. Diabetes 32: 685, 1983.PubMedCrossRefGoogle Scholar
  39. 39.
    Awoke S., Voyles N., Bhathena S.J., Taneneberg R.J., Recant L. Alterations of plasma opioid activity in human diabetics. Life Sci. 34: 1999, 1984.PubMedCrossRefGoogle Scholar
  40. 40.
    Hart I.C., Cowie A.T. Effect of morphine, naloxone and an enkephalin analogue on plasma prolactin, growth hormone, insulin and thyroxine in goats. J. Endocrinol. 77: 16, 1978.CrossRefGoogle Scholar
  41. 41.
    Schusdziarra V., Specht J., Schick R., De la Fuente A., Holland A., Pfeiffer E.F. Effect of morphine, leu-enkephalin and β-casomorphins on basal somatostatin release in dogs. Horm. Metab. Res. 15: 407, 1983.PubMedCrossRefGoogle Scholar
  42. 42.
    Schusdziarra V., Schick A., De la Fuente A., Specht J., Klier M., Brantl V., Pfeiffer E.V. Effect of β-casomorphins and analogs on insulin release in dogs. Endocrinology 112: 885, 1983.PubMedCrossRefGoogle Scholar
  43. 43.
    Stubbs W.A., Jones A., Edwards C.R.W., Delitala G., Jeffcoate W.J., Ratter S.J., Besser G.M., Bloom S.R., Alberti K.G.M.M. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 2: 1225, 1978.PubMedCrossRefGoogle Scholar
  44. 44.
    Jeanrenaud X., Maeder E., Del Pozo E., Felber J.P. Effect of an enkephalin analogue (FK 33-824) on glucose tolerance in man. Acta Endocrinol. (Kbh.) 104: 85, 1983.Google Scholar
  45. 45.
    Reid R.L., Yen S.S.C. β-endorphin stimulates the secretion of insulin and glucagon in humans. J. Clin. Endocrinol. Metab. 52: 592, 1981.PubMedCrossRefGoogle Scholar
  46. 46.
    Feldman M., Kiser R.S., Unger R.H., Li C.H. β-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings. N. Engl. J. Med. 308: 349, 1983.PubMedCrossRefGoogle Scholar
  47. 47.
    Reid R.L., Sandler J.A., Yen S.S.C. β-endorphin stimulates the secretion of insulin and glucagon in diabetes mellitus. Metabolism 23: 197, 1984.CrossRefGoogle Scholar
  48. 48.
    Morley J.E., Baranetsky N.G., Wingert T.D. Endocrine effects on naloxone-induced opiate receptor blockade. J. Clin. Endocrinol. Metab. 50: 251, 1980.PubMedCrossRefGoogle Scholar
  49. 49.
    Giugliano D., Ceriello A., Di Pinto P., Saccomanno F., Gentile S., Cacciapuoti F. Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade. Diabetes 31: 367, 1982.PubMedCrossRefGoogle Scholar
  50. 50.
    Serri O., Rasio E., Somma M. Effects of naloxone on insulin-induced release of pituitary hormones. J. Clin. Endocrinol, Metab. 53: 206, 1981.CrossRefGoogle Scholar
  51. 51.
    Wakabayashi I., Demura R., Miki N., Ohmura E., Miyoshi H., Shizume K. Failure of naloxone to influence plasma growth hormone, prolactin, and Cortisol secretions induced by insulin hypoglycaemia. J. Clin. Endocrinol. Metab. 50: 597, 1980.PubMedCrossRefGoogle Scholar
  52. 52.
    Bright G.M., Kaiser D.L., Rogol A.D., Clarke W.L. Naloxone attenuates recovery from insulin-induced hypoglycaemia in normal man. J. Clin. Endocrinol. Metab. 57: 213, 1983.PubMedCrossRefGoogle Scholar
  53. 53.
    Copolov D., Jethwa J., Stern A., Clements J., Funder J.W. Insulin hypoglycaemia and cholinergic blockade: response of plasma immunoreactive β-endorphin. Clin. Endocrinol. (Oxf.) 19: 575, 1983.CrossRefGoogle Scholar
  54. 54.
    Armistead J.G., Lightman S.L., Brown M.J., Causon R.C., Vaughan N.J.A. The effect of selective and non-selective β-adrenoreceptor blockade, and of naloxone infusion, on the hormonal mechanisms of recovery from insulin-induced hypolycaemia in man. Br. J. Clin. Pharmacol. 16: 718, 1983.CrossRefGoogle Scholar
  55. 55.
    Giugliano D., Ceriello A., Quatraro A., Paolisso G., Varano R., D’Onofrio F. Interaction between epinephrine, prostaglandin E, and metenkephalin in the regulation of insulin release in man. Diabete Metab. 11: 295, 1985.PubMedGoogle Scholar
  56. 56.
    Passariello N., Giugliano D., Quatraro A., Consoli G., Sgambato S., Torella R., D’Onofrio F. Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism 23: 1163, 1983.CrossRefGoogle Scholar
  57. 57.
    Giugliano D. Morphine, opioid peptides, and pancreatic islet function. Diabetes Care 7: 92, 1984.PubMedCrossRefGoogle Scholar
  58. 58.
    Morley J.E., Yamada T., Walsh J.H., Lamers C.B., Wong H., Shulkes A., Damassa D.A., Gordon J., Carlson H.E., Hershman J. Morphine addiction and withdrawal alters brain peptide concentrations. Life Sci. 26: 2239, 1980.PubMedCrossRefGoogle Scholar
  59. 59.
    Leslie R.D.G., Pyke D.A., Stubbs W.A. Sensitivity to enkephalin as a cause of non-insulin dependent diabetes. Lancet 1: 341, 1979.PubMedCrossRefGoogle Scholar
  60. 60.
    Johnston C., Wiles P.G., Medbak S., Bowcock S., Cooke E.D., Pyke D.A., Rees L.H. The role of endogenous opioids in the chlorpropamide alcohol flush. Clin. Endocrinol. (Oxf.) 21: 489, 1984.CrossRefGoogle Scholar
  61. 61.
    Recant L., Voyles N., Wade A., Awoke S., Bhathena S.J. Studies on the role of opiate peptides in two forms of genetic obesity: ob/ob mouse and fa/fa rat. Horm. Metab. Res. 15: 589, 1983.PubMedCrossRefGoogle Scholar
  62. 62.
    Greenberg J., Ellyin F., Pullen G., Ehrenpreis S., Singh S.P., Cheng J. Methionine-enkephalin and α-endorphin levels in brain, pancreas and adrenals of db/db mice. Endocrinology 116: 328, 1985.PubMedCrossRefGoogle Scholar
  63. 63.
    Garthwaite T.L., Martinson D.R., Tseng L.F., Hagen T.C., Menahan L.A. A longitudinal hormonal profile of the genetically obese mouse. Endocrinology 107: 671, 1980.PubMedCrossRefGoogle Scholar
  64. 64.
    Ono T., Oomura Y., Nishino H., Sasaki K., Muramoto K., Yano I. Morphine and enkephalin effects on hypothalamic glucoresponsive neurons. Brain Res. 185: 208, 1980.PubMedCrossRefGoogle Scholar
  65. 65.
    Matsumura M., Yamanoi A., Sato K., Tsuda M., Chikamari K., Mori H., Saito S. Alterations in the levels of β-endorphin-like immunoreactivity in plasma and tissues of obese rats with hypothalamic lesions. Horm. Metab. Res. 16: 105, 1984.PubMedCrossRefGoogle Scholar
  66. 66.
    Hershon K.S., Bierman E.L., Bruzzone C.M. Insulin responses to glucose in non-insulin dependent diabetic subjects with and without the chlorpropamide alcohol flush: effect of salicylate and naloxone. Diabetes Care 5: 404, 1982.PubMedCrossRefGoogle Scholar
  67. 67.
    Giugliano D. Acetylsalicylic acid in diabetes. Lancet 1: 560, 1981.PubMedCrossRefGoogle Scholar
  68. 68.
    Giugliano D., Ceriello A., Saccomanno F., Quatraro A., Paolisso G., D’Onofrio F. Effects of salicylate, tolbutamide and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 61: 160, 1985.PubMedCrossRefGoogle Scholar
  69. 69.
    Giugliano D., Torella R.; Improta L. Effects of prostaglandin E1 and prostaglandins F2a on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man. Diabete Metab. 4: 187, 1978.PubMedGoogle Scholar
  70. 70.
    Giugliano D., Di Pinto P., Ceriello A., Saccomanno F., Passariello N., D’Onofrio F. Impaired insulin secretion in human diabetes mellitus. Interactions between naloxone, phentolamine and lysine acetylsalicylate upon glucose induced insulin release. Diabete Metab. 11: 350, 1985.PubMedGoogle Scholar
  71. 71.
    Boufoux P.M., Grossman A., Lytras N., Besser G.M. Evidence for the participation of endogenous opioids in the sympathoadrenal response to hypoglycaemia in man. Clin. Endocrinol. (Oxf.) 22: 49, 1985.CrossRefGoogle Scholar
  72. 72.
    Schusdziarra V., Henrichs I., Holland A., Klier M., Pfeiffer E.F. Evidence for an effect of exorphins on plasma insulin and glucagon levels in dogs. Diabetes 30: 362, 1981.PubMedCrossRefGoogle Scholar
  73. 73.
    Schusdziarra V., Schick R., De la Fuente A., Holland A., Brantl V., Pfeiffer E.F. Effect of β-casomorphins on somatostatin release in dogs. Endocrinology 112: 1948, 1983.PubMedCrossRefGoogle Scholar
  74. 74.
    Brantl V., Teschemacher H., Henschen A. Novel opioid peptides derived from casein (β-casomorphin). Hoppe Seylers Z. Physiol. Chem. 360: 1211, 1979.PubMedCrossRefGoogle Scholar
  75. 75.
    Schusdziarra V., Holland A., Schick R., De la Fuente A., Klier M., Maier V., Brantl V., Pfeiffer E.F. Modulation of post-prandial insulin release by ingested opiate-like substances in dogs. Diabetologia 24: 113, 1983.PubMedCrossRefGoogle Scholar
  76. 76.
    Morley J.E., Levine A.S., Yamada T., Gebhard R.L., Prigge F., Shafer R.B., Goetz F.C., Silvis S.E. Effect of exorphins on gastrointestinal function, hormonal release, and appetite. Gastroenterology 84: 1517, 1983.PubMedGoogle Scholar
  77. 77.
    Giugliano D., Ceriello A., Quatraro A., D’Onofrio F. Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. Lancet 2: 769, 1985.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1987

Authors and Affiliations

  • A. Lala
    • 1
  • P. Bouloux
    • 2
  • G. Tamburrano
    • 1
  • E. Gale
    • 3
  1. 1.I Cattedra di Endocrinologia, II Clinica MedicaUniversità di Roma “La Sapienza”RomaItaly
  2. 2.Department of EndocrinologySt. Bartholomew’s HospitalLondon EC1UK
  3. 3.Department of Diabetes and ImmunogeneticsSt. Bartholomew’s HospitalLondon EC1UK

Personalised recommendations